SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (619)3/12/2003 9:11:38 AM
From: nigel bates  Read Replies (1) of 724
 
Sunesis If they can do this...
Message 18689503
...In addition, as reported in the PNAS study, the Company's scientists found adaptive sites in the target protein that are not evident upon inspection of x-ray crystal structure data of the native protein. They report that the IL-2 protein surface changed its conformation in the presence of tethered fragments. Dr. Wells commented, "These observations underscore the value and potential of an empirical process like Tethering to probe for adaptive binding sites on a target. Traditional structure-based approaches often do not provide sufficient insight for progressing potent leads against these more challenging but highly relevant disease targets."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News